| Phar 440- Day 1 |
History of Pharmacy & Health Insurance |
Unfinished |
2014-09-10 |
lhammeren |
59 |
1 |
edit |
|
| Phar 440 Day 1.0 |
Articles |
Unfinished |
2014-09-05 |
lhammeren |
19 |
0 |
edit |
|
| Phar 440 Day 2 |
Healthcare Economics, Insurance & Market |
Unfinished |
2014-09-10 |
lhammeren |
75 |
0 |
edit |
|
| Phar 440 Day 2.0 |
Day 2 Articles |
Unfinished |
2014-09-08 |
lhammeren |
18 |
0 |
edit |
|
| Phar 440 Day 3 |
Adherence, cost, quality, & access in healthcare |
Unfinished |
2014-09-09 |
lhammeren |
26 |
0 |
edit |
|
| Phar 440 Day 3.0 |
Day 3 Articles |
Unfinished |
2014-09-09 |
lhammeren |
12 |
0 |
edit |
|
| Phar 440 Day 4 |
Public health; drug use, development, distribution |
Unfinished |
2014-09-09 |
lhammeren |
39 |
0 |
edit |
|
| Day 4.0 & 5.0 |
Day 4 & 5 Articles |
Unfinished |
2014-09-10 |
lhammeren |
14 |
0 |
edit |
|
| Day 5 |
Professional Pharmacy Organizations |
Unfinished |
2016-06-24 |
lhammeren |
16 |
1 |
edit |
|
| Phar 441 |
State Pharmacy Law |
Unfinished |
2014-09-11 |
lhammeren |
39 |
0 |
edit |
|
| Abbreviations |
Pharmacy Calculations |
Unfinished |
2014-09-30 |
lhammeren |
46 |
0 |
edit |
|
| Serotonin Modifers |
drugs which modify serotonin function |
Unfinished |
2014-12-13 |
lhammeren |
11 |
0 |
edit |
|
| NT Enzymes |
neurotransmitter enzymes |
Unfinished |
2014-12-12 |
lhammeren |
7 |
0 |
edit |
|
| ANS receptors |
What do the ANS receptors do when activated? |
Unfinished |
2014-12-12 |
lhammeren |
39 |
0 |
edit |
|
| D-Sympathomimetics |
Direct acting adrenergic agonists, dopaminergic agonists |
Unfinished |
2014-12-13 |
lhammeren |
26 |
0 |
edit |
|
| I-Sympathomimetics |
Indirect/ mixed acting adrenergic drugs |
Unfinished |
2014-12-13 |
lhammeren |
13 |
0 |
edit |
|
| Sympatholytics |
Direct and indirect acting adrenergic blockers |
Unfinished |
2014-12-13 |
lhammeren |
17 |
0 |
edit |
|
| Cholinergic drugs |
Direct and indirect acting cholinergic drugs |
Unfinished |
2014-12-13 |
lhammeren |
31 |
0 |
edit |
|
| Antipsychotics |
antipsychotics & antidepressants |
Unfinished |
2014-12-15 |
lhammeren |
37 |
0 |
edit |
|
| Parkinson's Disease |
Drugs for Parkinson's Disease |
Unfinished |
2014-12-16 |
lhammeren |
11 |
0 |
edit |
|
| Opioids |
opioids and non-opioid analgesics |
Unfinished |
2015-01-15 |
lhammeren |
38 |
0 |
edit |
|
| AD & Anesthetics |
Alzheimer's disease and anesthetics |
Unfinished |
2015-01-14 |
lhammeren |
34 |
0 |
edit |
|
| Dyslip. and Cardio |
Dyslipidemia drugs and intro to cardio |
Unfinished |
2015-01-15 |
lhammeren |
38 |
0 |
edit |
|
| HF & Angina |
Heart Failure and Angina Drugs |
Unfinished |
2015-01-15 |
lhammeren |
39 |
0 |
edit |
|
| Arrhythmias |
Drugs used to treat arrhythmias |
Unfinished |
2015-01-15 |
lhammeren |
33 |
0 |
edit |
|
| Urinary Incontinence |
Drugs used to treat urinary incontinence |
Unfinished |
2015-01-26 |
lhammeren |
24 |
0 |
edit |
|
| Erectile Dysfunction |
Drugs used to treat erectile dysfunction |
Unfinished |
2015-01-26 |
lhammeren |
23 |
0 |
edit |
|
| Muscle Relaxants |
Drugs used as skeletal muscle relaxants |
Unfinished |
2015-01-26 |
lhammeren |
23 |
0 |
edit |
|
| GI Pharmacology |
Drugs for GI disorders |
Unfinished |
2015-01-28 |
lhammeren |
102 |
0 |
edit |
|
| Medical Abbreviation |
medical abbreviations page 2 & 3 |
Unfinished |
2015-05-18 |
lhammeren |
99 |
0 |
edit |
|
| Dosage Forms |
Drug degredation and exipients |
Unfinished |
2015-02-12 |
lhammeren |
50 |
0 |
edit |
|
| Conversion Factors |
Conversion Factors |
Unfinished |
2015-02-19 |
lhammeren |
10 |
0 |
edit |
|
| Topical |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-25 |
lhammeren |
52 |
0 |
edit |
|
| Pulmonary |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-25 |
lhammeren |
48 |
0 |
edit |
|
| Rectal |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-25 |
lhammeren |
30 |
0 |
edit |
|
| Ocular |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-26 |
lhammeren |
38 |
0 |
edit |
|
| Otic |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-26 |
lhammeren |
20 |
0 |
edit |
|
| Parenteral |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-26 |
lhammeren |
32 |
0 |
edit |
|
| Implants |
Pharmaceutical Dosage Forms |
Unfinished |
2015-02-26 |
lhammeren |
9 |
0 |
edit |
|
| Compounding |
Sterile & Non-sterile |
Unfinished |
2015-02-26 |
lhammeren |
61 |
0 |
edit |
|
| Geriatrics |
Drug considerations for geriatric patients |
Unfinished |
2015-03-25 |
lhammeren |
20 |
0 |
edit |
|
| Hemostasis |
Clotting Cascade and drugs which affect it |
Unfinished |
2015-04-14 |
lhammeren |
99 |
0 |
edit |
|
| allergy and asthma |
antihistamines |
Unfinished |
2015-04-28 |
lhammeren |
38 |
0 |
edit |
|
| Pain & Fever |
analgesic, anti-inflammatory, and antipyretic drugs |
Unfinished |
2015-04-28 |
lhammeren |
27 |
0 |
edit |
|
| Immunizations |
immune system function and immunizations |
Unfinished |
2015-04-29 |
lhammeren |
78 |
0 |
edit |
|
| toxicology |
toxicology terms and concepts |
Unfinished |
2015-05-08 |
lhammeren |
47 |
0 |
edit |
|
| toxicology II |
toxic agents |
Unfinished |
2015-05-08 |
lhammeren |
55 |
0 |
edit |
|
| Anticoagulation |
anti-thrombotics |
Unfinished |
2015-11-05 |
lhammeren |
74 |
0 |
edit |
|
